Compare ImmunityBio Inc. Common Stock (IBRX) vs Navan Inc. Class A Common Stock (NAVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Navan Inc. Class A Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B), while Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Navan Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Navan Inc. Class A Common Stock for 1 Days on average.
| IBRX | NAVN | |
|---|---|---|
Market Cap | $10.51B | $6.01B |
Volume | 10,445,785 | 2,990,425 |
Sector | Health | Technology |
52-Week High | $11.55 | $30.58 |
52-Week Low | $1.98 | $8.51 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $5.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →
